Amylyx Pharmaceuticals, Inc. Common Stock (AMLX)
Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
33. 81
+0.06
+0.1778%
After Hours
$
+2.19 +6.4774% 36. 00
3.75B Market Cap
- P/E Ratio
- Div Yield
1.82M Volume
- Eps
$ 33.75
Previous Close 
Want to track AMLX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Amylyx Pharmaceuticals, Inc. Common Stock (AMLX) Statistics
Valuation metrics
Market Cap 3.75B
Enterprise value 3.82B
Trailing P/E (ttm) -24.64
Forward P/E -
PEG ratio -0.42
Price/Sales (ttm) -
Price/Book (mrq) 16.15
Enterprise Value/Revenue -
Enterprise Value/EBITDA -25.49
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.36M
Average volume (90 days) 1.87M
Price summary
52-Week low 9.14
52-Week high 41.14
Beta -
50-Day moving average 22.05
200-Day moving average 15.58
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.57%
Return on equity -0.53%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.37
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.26
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 12.12%
Book value per share (mrq) 2.15
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
